Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
IMPDH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD83B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CIZ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMSB4X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
U2AF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARPC1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM205 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPZB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTOV1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on